"Breakthrough in Sleeping Sickness Treatment with Fexinidazole Discovery"

The European Medicines Agency has endorsed fexinidazole, an oral medication, as a safer and highly effective treatment for sleeping sickness, with a 97% cure rate for the acute form of the disease. This development is a significant improvement over the previous toxic treatments. Despite the success, challenges in drug distribution, diagnosis, and the potential for complacency remain, requiring ongoing vigilance in the fight against this parasitic disease.